| UniProt ID | BNI3L_HUMAN | |
|---|---|---|
| UniProt AC | O60238 | |
| Protein Name | BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like | |
| Gene Name | BNIP3L | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 219 | |
| Subcellular Localization |
Nucleus envelope. Endoplasmic reticulum. Mitochondrion outer membrane. Membrane Single-pass membrane protein . Colocalizes with SPATA18 at the mitochondrion outer membrane. |
|
| Protein Description | Induces apoptosis. Interacts with viral and cellular anti-apoptosis proteins. Can overcome the suppressors BCL-2 and BCL-XL, although high levels of BCL-XL expression will inhibit apoptosis. Inhibits apoptosis induced by BNIP3. Involved in mitochondrial quality control via its interaction with SPATA18/MIEAP: in response to mitochondrial damage, participates in mitochondrial protein catabolic process (also named MALM) leading to the degradation of damaged proteins inside mitochondria. The physical interaction of SPATA18/MIEAP, BNIP3 and BNIP3L/NIX at the mitochondrial outer membrane regulates the opening of a pore in the mitochondrial double membrane in order to mediate the translocation of lysosomal proteins from the cytoplasm to the mitochondrial matrix. May function as a tumor suppressor.. | |
| Protein Sequence | MSSHLVEPPPPLHNNNNNCEENEQSLPPPAGLNSSWVELPMNSSNGNDNGNGKNGGLEHVPSSSSIHNGDMEKILLDAQHESGQSSSRGSSHCDSPSPQEDGQIMFDVEMHTSRDHSSQSEEEVVEGEKEVEALKKSADWVSDWSSRPENIPPKEFHFRHPKRSVSLSMRKSGAMKKGGIFSAEFLKVFIPSLFLSHVLALGLGIYIGKRLSTPSASTY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 34 | Phosphorylation | PPPAGLNSSWVELPM CCCCCCCCCEEECCC | 30.53 | - | |
| 35 | Phosphorylation | PPAGLNSSWVELPMN CCCCCCCCEEECCCC | 33.78 | - | |
| 62 | Phosphorylation | GGLEHVPSSSSIHNG CCCCCCCCCCCCCCC | 41.59 | 23401153 | |
| 63 | Phosphorylation | GLEHVPSSSSIHNGD CCCCCCCCCCCCCCC | 23.26 | 23401153 | |
| 64 | Phosphorylation | LEHVPSSSSIHNGDM CCCCCCCCCCCCCCH | 37.33 | 30266825 | |
| 65 | Phosphorylation | EHVPSSSSIHNGDME CCCCCCCCCCCCCHH | 29.79 | 30266825 | |
| 82 | Phosphorylation | LLDAQHESGQSSSRG EEEHHCCCCCCCCCC | 39.75 | 29255136 | |
| 85 | Phosphorylation | AQHESGQSSSRGSSH HHCCCCCCCCCCCCC | 33.53 | 29255136 | |
| 86 | Phosphorylation | QHESGQSSSRGSSHC HCCCCCCCCCCCCCC | 19.03 | 25849741 | |
| 87 | Phosphorylation | HESGQSSSRGSSHCD CCCCCCCCCCCCCCC | 46.00 | 29255136 | |
| 90 | Phosphorylation | GQSSSRGSSHCDSPS CCCCCCCCCCCCCCC | 18.79 | 30108239 | |
| 91 | Phosphorylation | QSSSRGSSHCDSPSP CCCCCCCCCCCCCCC | 30.84 | 30108239 | |
| 95 | Phosphorylation | RGSSHCDSPSPQEDG CCCCCCCCCCCCCCC | 32.44 | 30576142 | |
| 95 | Ubiquitination | RGSSHCDSPSPQEDG CCCCCCCCCCCCCCC | 32.44 | - | |
| 96 | Ubiquitination | GSSHCDSPSPQEDGQ CCCCCCCCCCCCCCC | 36.46 | - | |
| 97 | Phosphorylation | SSHCDSPSPQEDGQI CCCCCCCCCCCCCCE | 43.07 | 30576142 | |
| 114 | Ubiquitination | DVEMHTSRDHSSQSE EEEEECCCCCCCCCH | 46.98 | - | |
| 117 | Phosphorylation | MHTSRDHSSQSEEEV EECCCCCCCCCHHHH | 34.07 | 23401153 | |
| 118 | Phosphorylation | HTSRDHSSQSEEEVV ECCCCCCCCCHHHHH | 34.01 | 25159151 | |
| 120 | Phosphorylation | SRDHSSQSEEEVVEG CCCCCCCCHHHHHHC | 49.26 | 29255136 | |
| 129 | Ubiquitination | EEVVEGEKEVEALKK HHHHHCHHHHHHHHH | 77.30 | - | |
| 135 | Ubiquitination | EKEVEALKKSADWVS HHHHHHHHHHCCHHH | 52.29 | - | |
| 136 | Ubiquitination | KEVEALKKSADWVSD HHHHHHHHHCCHHHC | 52.29 | - | |
| 137 | Phosphorylation | EVEALKKSADWVSDW HHHHHHHHCCHHHCC | 29.85 | 27251275 | |
| 137 | Ubiquitination | EVEALKKSADWVSDW HHHHHHHHCCHHHCC | 29.85 | - | |
| 139 | Ubiquitination | EALKKSADWVSDWSS HHHHHHCCHHHCCCC | 54.09 | 21890473 | |
| 154 | Ubiquitination | RPENIPPKEFHFRHP CCCCCCCCHHCCCCC | 68.60 | 21890473 | |
| 154 | Ubiquitination | RPENIPPKEFHFRHP CCCCCCCCHHCCCCC | 68.60 | 21890473 | |
| 164 | Phosphorylation | HFRHPKRSVSLSMRK CCCCCCCCEEEEECC | 23.37 | 30266825 | |
| 166 | Phosphorylation | RHPKRSVSLSMRKSG CCCCCCEEEEECCCC | 18.90 | 23401153 | |
| 168 | Phosphorylation | PKRSVSLSMRKSGAM CCCCEEEEECCCCCC | 14.72 | 23401153 | |
| 176 | Acetylation | MRKSGAMKKGGIFSA ECCCCCCCCCCCCCH | 47.97 | 12431203 | |
| 177 | Ubiquitination | RKSGAMKKGGIFSAE CCCCCCCCCCCCCHH | 49.65 | - | |
| 219 | Phosphorylation | STPSASTY------- CCCCCCCC------- | 17.67 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BNI3L_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BNI3L_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BNI3L_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| DOK5_HUMAN | DOK5 | physical | 16189514 | |
| EWS_HUMAN | EWSR1 | physical | 16189514 | |
| BNI3L_HUMAN | BNIP3L | physical | 16189514 | |
| TMM11_HUMAN | TMEM11 | physical | 16189514 | |
| ROBO2_HUMAN | ROBO2 | physical | 21900206 | |
| GNB5_HUMAN | GNB5 | physical | 21900206 | |
| KLH23_HUMAN | KLHL23 | physical | 21900206 | |
| GBP2_HUMAN | GBP2 | physical | 21900206 | |
| MLP3A_HUMAN | MAP1LC3A | physical | 20010802 | |
| BNIP3_HUMAN | BNIP3 | physical | 19060904 | |
| ECM1_HUMAN | ECM1 | physical | 21988832 | |
| CSKP_HUMAN | CASK | physical | 21988832 | |
| KCC1D_HUMAN | CAMK1D | physical | 21988832 | |
| DUS3_HUMAN | DUSP3 | physical | 21988832 | |
| BNI3L_HUMAN | BNIP3L | physical | 25416956 | |
| TMM11_HUMAN | TMEM11 | physical | 25416956 | |
| SMCO4_HUMAN | SMCO4 | physical | 25416956 | |
| CLC7A_HUMAN | CLEC7A | physical | 25416956 | |
| FATE1_HUMAN | FATE1 | physical | 25416956 | |
| LRAD1_HUMAN | LDLRAD1 | physical | 25416956 | |
| BNIP3_HUMAN | BNIP3 | physical | 26186194 | |
| BNI3L_HUMAN | BNIP3L | physical | 21516116 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-120, AND MASSSPECTROMETRY. | |